New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
16:05 EDTRPTPRaptor Pharmaceuticals appoints Julie Anne Smith as president, CEO
Raptor Pharmaceuticals announced that Julie Anne Smith, executive VP, strategy and COO at Raptor, has been named president and CEO effective immediately. Smith will succeed Christopher Starr as CEO and will join the board effective January 1, 2015. Starr will continue working closely with Smith during this transition period, will remain on the board and will consult on Raptor development projects following the succession. Smith joined Raptor in September 2012 as executive VP, strategy and COO.
News For RPTP From The Last 14 Days
Check below for free stories on RPTP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 15, 2014
08:58 EDTRPTPRaptor Pharma should be owned ahead of potential catalysts, says JMP Securities
JMP Securities believes that Raptor has a number of potentially transformative upcoming catalysts. The firm thinks that adoption of the company's Proscybi drug could be a number of times higher than current levels, and it thinks that data due to be released over the next several months could be transformative for the company. The firm reiterates a $33 price target and Outperform rating.
September 11, 2014
09:38 EDTRPTPRaptor Pharmaceuticals management to meet with JMP Securities
Subscribe for More Information
September 3, 2014
09:09 EDTRPTPRaptor Pharmaceuticals raises dividend by 7% to 20c per share
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use